Abstract
YAMAMOTO, T., KIMURA, T., OTA, K., SHOJI, M., INOUE, M., OHTA, M., SATO, K., FUNYU, T. and ABE, K. Effects of a Nitric Oxide Synthase Inhibitor on Vasopressin and Atrial Natriuretic Hormone Release, Thermogenesis and Cardiovascular Function in Response to Interleukin-1β in Rats. Tohoku J. Exp. Med., 1994, 174 (1), 59-69 - To assess whether nitric oxide (NO) formed by IL-1β affects vasopressin (AVP) and atrial natriuretic hormone (ANH) release and the regulation of blood pressure and body temperature, intravenous infusion of either Nω-nitro-L-arginine methyl ester (L-NAME) alone (50μg/kg•body weigh•min for 135min), human recombinant interleukin 1β(IL-1β) alone (750ng/kg•body weight•min for 120min), or L-NAME (50μg/kg•body weight•min for 135min) with IL-1β (750ng/kg•body weight•min for 120 min), was performed following priming doses of L-NAME (2mg/kg•body weight) and IL-1β (7.5μg/kg•body weight) into conscious rats (n=6 each). In the control group, saline alone was administered. Plasma AVP and ANH, mean arterial blood pressure (MABP), heart rate (HR) and rectal temperature (RT) were determined. In response to L-NAME, plasma AVP significantly increased, but plasma ANH did not change, despite increases in MABP and decreases in HR. In response to IL-1β, both plasma AVP and ANH increased with decreases in MABP and RT without any changes in HR. With L-NAME and IL-1β, both plasma AVP and ANH increased, and depressor response to IL-1β was partly attenuated by L-NAME, without any changes in RT. With saline alone, none of these parameters changed during the study. These results suggest that NO may directly affect the release of AVP and ANH and the regulation of body temperature and blood pressure, but NO formed by IL-1β may not have direct effects on the release of these hormones, and the regulation of blood pressure and temperature.
